Clinical Trial Update: Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

View source ↗

Summary

A clinical trial is currently recruiting to evaluate the Mixed Molecular Clinical Index (MMCI) in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Diffuse Large B Cell Lymphoma | Status: RECRUITING